Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
1.225
+0.005 (0.41%)
Jun 22, 2026, 11:12 AM EDT - Market open
Filana Therapeutics Employees
As of December 31, 2025, Filana Therapeutics had 20 total employees, including 17 full-time and 3 part-time employees. The number of employees decreased by 10 or -33.33% compared to the previous year.
Employees
20
Change (1Y)
-10
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$3,895,050
Market Cap
59.18M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 20 | -10 | -33.33% | 17 | 3 |
| Dec 31, 2024 | 30 | 1 | 3.45% | 30 | 0 |
| Dec 31, 2023 | 29 | 3 | 11.54% | 29 | 0 |
| Dec 31, 2022 | 26 | 2 | 8.33% | 26 | 0 |
| Dec 31, 2021 | 24 | 13 | 118.18% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 139 |
| Seres Therapeutics | 66 |
| PMV Pharmaceuticals | 54 |
| Entera Bio | 22 |
| iBio, Inc. | 20 |
| Context Therapeutics | 15 |
| MiNK Therapeutics | 15 |
| Eloxx Pharmaceuticals | 10 |
FLNA News
- 11 days ago - Filana Therapeutics Transcript: AGM 2026 - Transcripts
- 27 days ago - Filana Therapeutics resumed with Buy at Maxim on rebranding, strategic pivot - TheFly
- 27 days ago - Filana Therapeutics resumed with a Buy at Maxim - TheFly
- 6 weeks ago - Filana Therapeutics Reports Q1 2026 Financial Results and Business Update - GlobeNewsWire
- 6 weeks ago - Filana Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Filana Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Filana Therapeutics Slides: Corporate presentation - Filings
- 6 weeks ago - Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII - GlobeNewsWire